Cargando…

Very Late Stent Thrombosis after Discontinuation of Antiplatelet Agents during Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining after Implantation of a Second-generation Drug-eluting Stent

A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myocardial infarction, and peri-stent contrast staining had been observed at the stent implantation site. The patient previously underwent anticoagulation therapy for left ventricular thrombus an...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Akihiro, Morita, Yusuke, Yasuda, Yu, Kawahara, Hiroshi, Kagawa, Yuzo, Tanabe, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107992/
https://www.ncbi.nlm.nih.gov/pubmed/34565779
http://dx.doi.org/10.2169/internalmedicine.8274-21
_version_ 1784708606856265728
author Endo, Akihiro
Morita, Yusuke
Yasuda, Yu
Kawahara, Hiroshi
Kagawa, Yuzo
Tanabe, Kazuaki
author_facet Endo, Akihiro
Morita, Yusuke
Yasuda, Yu
Kawahara, Hiroshi
Kagawa, Yuzo
Tanabe, Kazuaki
author_sort Endo, Akihiro
collection PubMed
description A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myocardial infarction, and peri-stent contrast staining had been observed at the stent implantation site. The patient previously underwent anticoagulation therapy for left ventricular thrombus and antiplatelet therapy to prevent stent thrombosis. More than one year after implantation of a drug-eluting stent, antiplatelet drugs were discontinued, and anticoagulant alone was prescribed according to the guidelines, which resulted in very late stent thrombosis. The risks of both bleeding and thrombosis must be fully considered when deciding whether or not to discontinue antiplatelet therapy during anticoagulation therapy.
format Online
Article
Text
id pubmed-9107992
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-91079922022-05-27 Very Late Stent Thrombosis after Discontinuation of Antiplatelet Agents during Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining after Implantation of a Second-generation Drug-eluting Stent Endo, Akihiro Morita, Yusuke Yasuda, Yu Kawahara, Hiroshi Kagawa, Yuzo Tanabe, Kazuaki Intern Med Case Report A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myocardial infarction, and peri-stent contrast staining had been observed at the stent implantation site. The patient previously underwent anticoagulation therapy for left ventricular thrombus and antiplatelet therapy to prevent stent thrombosis. More than one year after implantation of a drug-eluting stent, antiplatelet drugs were discontinued, and anticoagulant alone was prescribed according to the guidelines, which resulted in very late stent thrombosis. The risks of both bleeding and thrombosis must be fully considered when deciding whether or not to discontinue antiplatelet therapy during anticoagulation therapy. The Japanese Society of Internal Medicine 2021-09-25 2022-04-15 /pmc/articles/PMC9107992/ /pubmed/34565779 http://dx.doi.org/10.2169/internalmedicine.8274-21 Text en Copyright © 2022 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Endo, Akihiro
Morita, Yusuke
Yasuda, Yu
Kawahara, Hiroshi
Kagawa, Yuzo
Tanabe, Kazuaki
Very Late Stent Thrombosis after Discontinuation of Antiplatelet Agents during Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining after Implantation of a Second-generation Drug-eluting Stent
title Very Late Stent Thrombosis after Discontinuation of Antiplatelet Agents during Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining after Implantation of a Second-generation Drug-eluting Stent
title_full Very Late Stent Thrombosis after Discontinuation of Antiplatelet Agents during Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining after Implantation of a Second-generation Drug-eluting Stent
title_fullStr Very Late Stent Thrombosis after Discontinuation of Antiplatelet Agents during Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining after Implantation of a Second-generation Drug-eluting Stent
title_full_unstemmed Very Late Stent Thrombosis after Discontinuation of Antiplatelet Agents during Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining after Implantation of a Second-generation Drug-eluting Stent
title_short Very Late Stent Thrombosis after Discontinuation of Antiplatelet Agents during Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining after Implantation of a Second-generation Drug-eluting Stent
title_sort very late stent thrombosis after discontinuation of antiplatelet agents during anticoagulation therapy in a patient with peri-stent contrast staining after implantation of a second-generation drug-eluting stent
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107992/
https://www.ncbi.nlm.nih.gov/pubmed/34565779
http://dx.doi.org/10.2169/internalmedicine.8274-21
work_keys_str_mv AT endoakihiro verylatestentthrombosisafterdiscontinuationofantiplateletagentsduringanticoagulationtherapyinapatientwithperistentcontraststainingafterimplantationofasecondgenerationdrugelutingstent
AT moritayusuke verylatestentthrombosisafterdiscontinuationofantiplateletagentsduringanticoagulationtherapyinapatientwithperistentcontraststainingafterimplantationofasecondgenerationdrugelutingstent
AT yasudayu verylatestentthrombosisafterdiscontinuationofantiplateletagentsduringanticoagulationtherapyinapatientwithperistentcontraststainingafterimplantationofasecondgenerationdrugelutingstent
AT kawaharahiroshi verylatestentthrombosisafterdiscontinuationofantiplateletagentsduringanticoagulationtherapyinapatientwithperistentcontraststainingafterimplantationofasecondgenerationdrugelutingstent
AT kagawayuzo verylatestentthrombosisafterdiscontinuationofantiplateletagentsduringanticoagulationtherapyinapatientwithperistentcontraststainingafterimplantationofasecondgenerationdrugelutingstent
AT tanabekazuaki verylatestentthrombosisafterdiscontinuationofantiplateletagentsduringanticoagulationtherapyinapatientwithperistentcontraststainingafterimplantationofasecondgenerationdrugelutingstent